Literature DB >> 2384165

NADPH:O2 oxidoreductase of human eosinophils in the cell-free system.

B G Bolscher1, L Koenderman, A T Tool, P M Stokman, D Roos.   

Abstract

The NADPH oxidase of human eosinophils, measured in the cell-free system, shows the same characteristics as the enzyme from human neutrophils. All proteins required for activity of the enzyme are expressed in eosinophils at a higher level than in neutrophils. Eosinophils isolated from patients with chronic granulomatous disease show the same molecular defects as the neutrophils from these patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384165     DOI: 10.1016/0014-5793(90)81025-j

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Expression and translocation of Rac2 in eosinophils during superoxide generation.

Authors:  P Lacy; S Mahmudi-Azer; B Bablitz; M Gilchrist; P Fitzharris; D Cheng; S F Man; G M Bokoch; R Moqbel
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

2.  Synaptic localization of a functional NADPH oxidase in the mouse hippocampus.

Authors:  Maria V Tejada-Simon; Faridis Serrano; Laura E Villasana; Beatriz I Kanterewicz; Gang-Yi Wu; Mark T Quinn; Eric Klann
Journal:  Mol Cell Neurosci       Date:  2005-05       Impact factor: 4.314

3.  Voltage-activated proton current in eosinophils from human blood.

Authors:  D V Gordienko; M Tare; S Parveen; C J Fenech; C Robinson; T B Bolton
Journal:  J Physiol       Date:  1996-10-15       Impact factor: 5.182

4.  Molecular cloning of an Onchocerca volvulus extracellular Cu-Zn superoxide dismutase.

Authors:  E R James; D C McLean; F Perler
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Early signalling events implicated in leukotriene B4-induced activation of the NADPH oxidase in eosinophils: role of Ca2+, protein kinase C and phospholipases C and D.

Authors:  R S Perkins; M A Lindsay; P J Barnes; M A Giembycz
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

6.  Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma.

Authors:  Wenxin Xu; Monica Jones; Bai Liu; Xiaoyun Zhu; Christopher B Johnson; Ana C Edwards; Lin Kong; Emily K Jeng; Kaiping Han; Warren D Marcus; Mark P Rubinstein; Peter R Rhode; Hing C Wong
Journal:  Cancer Res       Date:  2013-05-03       Impact factor: 12.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.